13_3_4
Volume 13, Number 3, pages 69 - 75
Treatment and prevention of cytomegalovirus in renal transplant patients: Weighing the evidence
1.0 CE Hrs for Quiz
Alison Hakkert, pharmacy student, and Jennifer Dykeman-Sharpe, BSc Pharm
Objectives
After reading the article, the reader will be able to:
- Describe the risk factors for CMV infection and disease
- Discuss treatment of symptomatic CMV disease
- Discuss options for prevention of CMV disease post renal transplantation.
Author Affiliation(s): Alison Hakkert is a pharmacy student at Dalhousie University, Halifax, Nova Scotia. Jennifer Dykeman-Sharpe, BScPharm, is Renal Pharmacist, Clinical Coordinator, Pharmacy Services, Atlantic Health Sciences Corporation, Saint John, New Brunswick.